Oxidative Stress Clinical Trial
Official title:
The Effect of Sideritis Scardica (SidTea+) Extract Supplementation on Health and Oxidative Stress Biomarkers in Healthy Individuals
Verified date | December 2023 |
Source | University of Thessaly |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the present clinical study is to estimate the efficacy of a Sideritis Scardica extract (SidTea+), derived from the Greek mountain Taygetos, in regulating antioxidant and health biomarkers in healthy adults.
Status | Completed |
Enrollment | 30 |
Est. completion date | October 1, 2023 |
Est. primary completion date | May 25, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Healthy Individuals aged 18-65 years Exclusion Criteria: - Musculoskeletal injury - Dietary supplements - Medication |
Country | Name | City | State |
---|---|---|---|
Greece | Exercise Biochemistry, Physiology and Nutrition Laboratory, Department of Physical Education and Sport Science, University of Thessaly | Trikala | Thessaly |
Lead Sponsor | Collaborator |
---|---|
University of Thessaly |
Greece,
Gabrieli CN, Kefalas PG, Kokkalou EL. Antioxidant activity of flavonoids from Sideritis raeseri. J Ethnopharmacol. 2005 Jan 15;96(3):423-8. doi: 10.1016/j.jep.2004.09.031. Epub 2004 Nov 6. — View Citation
Tsaknis J, Lalas S. Extraction and identification of natural antioxidant from Sideritis euboea (mountain tea). J Agric Food Chem. 2005 Aug 10;53(16):6375-81. doi: 10.1021/jf0479261. — View Citation
Yao LH, Jiang YM, Shi J, Tomas-Barberan FA, Datta N, Singanusong R, Chen SS. Flavonoids in food and their health benefits. Plant Foods Hum Nutr. 2004 Summer;59(3):113-22. doi: 10.1007/s11130-004-0049-7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in glutathione concentration | Glutathione concentration will be analyzed in erythrocytes | Change from baseline to 1 month | |
Primary | Change in catalase activity | Catalase activity will be analyzed in erythrocytes | Change from baseline to 1 month | |
Primary | Change in total antioxidant capacity | Total antioxidant capacity will be analyzed in serum | Change from baseline to 1 month | |
Primary | Change in thiobarbituric acid reactive substances concentration | Thiobarbituric acid reactive substances concentration will be analyzed in plasma | Change from baseline to 1 month | |
Primary | Change in protein carbonyls concentration | Protein carbonyls will be analyzed in plasma | Change from baseline to 1 month | |
Primary | Change in glucose concentration | Glucose concentration will be analyzed in plasma | Change from baseline to 1 month | |
Primary | Change in cholesterol concentration | Cholesterol concentration will be analyzed in plasma | Change from baseline to 1 month | |
Primary | Change in triglycerides concentration | triglycerides concentration will be analyzed in plasma | Change from baseline to 1 month | |
Primary | Change in high-density lipoprotein concentration | High-density lipoprotein concentration will be analyzed in plasma | Change from baseline to 1 month | |
Primary | Change in bilirubin concentration | Bilirubin concentration will be analyzed in plasma | Change from baseline to 1 month | |
Primary | Change in lactate dehydrogenase concentration | Lactate dehydrogenase concentration will be analyzed in plasma | Change from baseline to 1 month | |
Primary | Change in serum glutamic-oxaloacetic transaminase concentration | Serum glutamic-oxaloacetic transaminase will be analyzed in serum | Change from baseline to 1 month | |
Primary | Change in gamma-glutamyl transpeptidase concentration | Gamma-glutamyl transpeptidase concentration will be analyzed in serum | Change from baseline to 1 month | |
Primary | Change in creatinine concentration | Creatinine concentration will be analyzed in serum | Change from baseline to 1 month | |
Primary | Change in uric acid concentration | Uric acid concentration will be analyzed in serum | Change from baseline to 1 month | |
Secondary | Change in handgrip strength | Handgrip strength will be measured using a hand dynamometer | Change from baseline to 1 month | |
Secondary | Change in estimated maximal oxygen consumption (eVO2max) | eVO2max will be measured using an automated open-circuit spirometer | Change from baseline to 1 month | |
Secondary | Change in body weight | Body weight will be measured using a digital scale | Change from baseline to 1 month | |
Secondary | Change in body fat | Body fat will be measured by bioelectrical impedance analysis | Change from baseline to 1 month | |
Secondary | Change in resting heart rate | Resting heart rate will be measured using a heart rate sensor | Change from baseline to 1 month | |
Secondary | Change in diastolic and systolic blood pressure | Diastolic and systolic blood pressure will be measured using a manual sphygmomanometer | Change from baseline to 1 month | |
Secondary | Change in waist and hip circumference | Waist and hip circumference will be assessed using a tape measure | Change from baseline to 1 month | |
Secondary | Change in complete blood count | White blood cells, lymphocytes, monocytes, granulocytes, red blood cells and platelets will be analyzed in whole blood using an automated blood chemistry analyzer | Change from baseline to 1 month | |
Secondary | Dietary macro-nutrient analysis | Protein, carbohydrate and fat dietary intake will be measured using diet recalls (food questionnaires) | Baseline | |
Secondary | Dietary micro-nutrient analysis | Vitamin C, vitamin E, zinc, methionine and cysteine dietary intake will be analyzed using diet recalls (food questionnaires) | Baseline | |
Secondary | Physical activity level | Low, moderate and vigorous physical activity will be assessed by questionnaires | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04136821 -
The Long-term Effects of Oceanix™ on Resistance Training Adaptations
|
N/A | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Completed |
NCT03358524 -
Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia
|
Phase 4 | |
Recruiting |
NCT05327348 -
Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery
|
Phase 3 | |
Completed |
NCT03288623 -
The Effects of Dark Chocolate Implementation in Elite Athletes
|
N/A | |
Completed |
NCT04419025 -
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
|
Phase 2 | |
Completed |
NCT04597983 -
Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists
|
N/A | |
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
Enrolling by invitation |
NCT03030456 -
Whole Body Vibrations on Functional Capacity, Muscular Strength, and Biochemical Profile in Elders
|
N/A | |
Not yet recruiting |
NCT02202239 -
Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients
|
Phase 4 | |
Completed |
NCT02256254 -
SIMOX - Induction of Oxidative Stress
|
Phase 2 | |
Recruiting |
NCT02048592 -
Impact of Immunonutrition on the Patients With Cystic Fibrosis
|
Phase 4 | |
Completed |
NCT01942460 -
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
|
Phase 4 | |
Completed |
NCT02463318 -
The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects
|
N/A | |
Completed |
NCT01990391 -
Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities
|
N/A | |
Completed |
NCT02177383 -
Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance
|
N/A | |
Completed |
NCT00845130 -
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
|
N/A | |
Completed |
NCT00607893 -
Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT00247507 -
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
|
Phase 4 |